120 related articles for article (PubMed ID: 34402147)
1. Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review.
Martins LHI; Ferreira DC; Silva MT; Motta RHL; Franquez RT; Bergamaschi CC
Oral Dis; 2023 Jan; 29(1):75-99. PubMed ID: 34402147
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
[TBL] [Abstract][Full Text] [Related]
3. Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence.
Mendes V; Dos Santos GO; Calasans-Maia MD; Granjeiro JM; Moraschini V
Int J Oral Maxillofac Surg; 2019 Mar; 48(3):373-381. PubMed ID: 30314708
[TBL] [Abstract][Full Text] [Related]
4. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women.
Wotton CJ; Green J; Brown A; Armstrong MEG; Floud S; Beral V; Reeves GK;
Bone; 2019 Jul; 124():69-74. PubMed ID: 30959190
[TBL] [Abstract][Full Text] [Related]
5. Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
Somay E
Spec Care Dentist; 2024; 44(2):615-616. PubMed ID: 37515493
[No Abstract] [Full Text] [Related]
6. Dental Implant Failure in Post-Menopausal Women on Oral Bisphosphonates: A Systematic Review and Meta-Analysis.
Pishan B; Andrukhov O; Rausch-Fan X
J Oral Implantol; 2024 Jun; 50(3):288-295. PubMed ID: 38660740
[TBL] [Abstract][Full Text] [Related]
7. Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.
Lee SH; Chan RC; Chang SS; Tan YL; Chang KH; Lee MC; Chang HE; Lee CC
Support Care Cancer; 2014 Feb; 22(2):553-60. PubMed ID: 24203085
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects.
Nogueira D; Caldas IM; Dinis-Oliveira RJ
Arch Oral Biol; 2023 Nov; 155():105792. PubMed ID: 37611492
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics.
Soma T; Iwasaki R; Sato Y; Kobayashi T; Ito E; Matsumoto T; Kimura A; Miyamoto K; Matsumoto M; Nakamura M; Morita M; Asoda S; Kawana H; Nakagawa T; Miyamoto T
Sci Rep; 2022 Jan; 12(1):19. PubMed ID: 34997043
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report].
Wu PF; Li Y; Lei ZG; Chen LL
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Aug; 38(4):460-463. PubMed ID: 32865369
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiogram Changes Following Intravenous Bisphosphonate Infusion: A Systematic Review and Meta-Analysis.
Shoung A; Shoung N; Hii R; Nerlekar N; Ebeling PR; Rodríguez AJ
J Bone Miner Res; 2023 Nov; 38(11):1679-1688. PubMed ID: 37681243
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.
Daneshdoost SM; El Abiad JM; Ruble KJ; Jones LC; Crane JL; Morris CD; Levin AS
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e365-e370. PubMed ID: 32324697
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of guided autofluorescence laser therapy in MRONJ: a systematic review.
Dipalma G; Inchingolo AD; Piras F; Palmieri G; Pede CD; Ciocia AM; Siciliani RA; Olio FD; Inchingolo AM; Palermo A; Inchingolo F; Favia G; Limongelli L
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11817-11831. PubMed ID: 38164845
[TBL] [Abstract][Full Text] [Related]
15. Response to letter to the editor regarding, "Depletion of macrophages deteriorates bisphosphonate-related osteonecrosis of the jaw-like lesions in mice".
Kozutsumi R; Kuroshima S; Al-Omari FA; Hayano H; Nakajima K; Kakehashi H; Sawase T
Bone; 2024 Apr; 181():117010. PubMed ID: 38160961
[No Abstract] [Full Text] [Related]
16. Influence of the use of bisphosphonates on the development of postextraction sequelae: scoping review with mapping evidence of in vivo studies.
Dias MO; Menezes GPR; Tavares FOM; Leite KLF; Tenório JDR; Esteves JC; Prado R; Maia LC
J Dent; 2024 May; ():105051. PubMed ID: 38763386
[TBL] [Abstract][Full Text] [Related]
17. Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.
Soolari N; Soolari A
Open Dent J; 2011; 5():163-7. PubMed ID: 22135700
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of bisphosphonate-associated osteonecrosis of the jaws in individuals with rheumatoid arthritis - a systematic review.
Tenório JR; Estanho D; Silva LS; Pintor AV; Magno MB; Cavalcante IL; Andrade BA; Maia LC
Med Oral Patol Oral Cir Bucal; 2023 Dec; 29(3):e390-7. PubMed ID: 38150601
[TBL] [Abstract][Full Text] [Related]
19. A case of variegate porphyria in association with coeliac disease and bisphosphonate associated dental osteonecrosis.
Ogundipe OA
J Clin Med Res; 2009 Dec; 1(5):292-6. PubMed ID: 22481993
[TBL] [Abstract][Full Text] [Related]
20. Assessing dental surgeons' understanding of bisphosphonates: Implications for patient health in oral surgery.
Rocha Cortez Teles de Alencar V; Ribeiro Paulino M; Andrea Luna Martinis de Alencar I; Ribeiro-Filho J; Valéria de Oliveira Braz A; Fagner Ferreira Matias E; Paulo Martins de Lima J; Giesta Lemos Florencio S; Douglas Melo Coutinho H; Marcos Montagner A
Saudi Dent J; 2024 Jan; 36(1):180-186. PubMed ID: 38375400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
